AOTMP Announces Winners of the 2017 Mobility Awards
Jan 06, 2017 12:30 pm UTC| Business
INDIANAPOLIS, Jan. 06, 2017 -- AOTMP, a global leader in telecom management best practices and industry standards for enterprises and vendors, announced winners at its awards event, held at the Consumer Electronics Show...
Melco Crown Entertainment Announces New Appointments to Leadership Team
Jan 06, 2017 12:10 pm UTC| Business
MACAU, Jan. 06, 2017 -- Melco Crown Entertainment Limited (Nasdaq:MPEL) (“Melco Crown Entertainment”, ”MCE”, the “Company” or “we”), a developer, owner and operator of casino gaming and entertainment casino resort...
Jan 06, 2017 12:05 pm UTC| Business
SALT LAKE CITY, Jan. 06, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in personalized medicine, today announced that multiple Blue Cross Blue Shield (BCBS) affiliate plans have issued positive coverage...
Codexis to Offer High-Performance Enzymes for Diagnostics Markets
Jan 06, 2017 12:00 pm UTC| Business
REDWOOD CITY, Calif., Jan. 06, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will offer high-performance enzymes for customers using next generation sequencing (NGS) and...
BlueLinx Completes Another Property Sale and Continues to Advance Deleveraging Strategy
Jan 06, 2017 12:00 pm UTC| Business
ATLANTA, Jan. 06, 2017 -- BlueLinx Holdings Inc. (NYSE:BXC), announced today that it has recently completed the sale of its non-operating facility in Wausau, Wisconsin, generating approximately $1.1 million in net...
DuPont Fabros Technology Inc. Announces Successful Completion of 2016 SSAE 16 Audits
Jan 06, 2017 12:00 pm UTC| Business
WASHINGTON, Jan. 06, 2017 -- DuPont Fabros Technology Inc. (NYSE:DFT), a leading owner, developer, operator and manager of enterprise-class, carrier-neutral, large scale multi-tenant wholesale data centers, today...
VBL Therapeutics Announces Completion of Enrollment in the Pivotal GLOBE Study
Jan 06, 2017 12:00 pm UTC| Business
TEL AVIV, Israel, Jan. 06, 2017 -- VBL Therapeutics (NASDAQ:VBLT), announced today that it has completed enrollment in the GLOBE Phase 3 study evaluating the efficacy of its lead candidate ofranergene obadenovec...